Use of C-type natriuretic peptide as an indicator in detection of inducible peripheral ischemia

被引:1
|
作者
Caliskan, Ahmet [1 ]
Yazici, Suleyman [1 ]
Karahan, Oguz [1 ]
Guclu, Orkut [1 ]
Tezcan, Orhan [1 ]
Demirtas, Sinan [1 ]
Yildiz, Bekir [1 ]
Yavuz, Celal [1 ]
机构
[1] Dicle Univ, Fac Med, Dept Cardiovasc Surg, TR-21280 Diyarbakir, Turkey
来源
TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2014年 / 22卷 / 03期
关键词
C-type natriuretic peptide; ischemic response; peripheral ischemia; CONGESTIVE-HEART-FAILURE; B-TYPE; ARTERIAL-DISEASE; EXPRESSION; RECEPTOR;
D O I
10.5606/tgkdc.dergisi.2014.9378
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: In this experimental study, alterations in plasma C-type natriuretic peptide (CNP) levels were evaluated during the critical initial hours of peripheral ischemia. Methods: Forty male Sprague-Dawley type rats (aged 8 to 12 weeks, weighing 230 30 g) were included in the study. Four groups were created with 10 rats namely control group, group 1, group 2, and group 3. Baseline plasma CNP levels were detected in the control group without any intervention, while the plasma CNP levels were determined in the second hour of peripheral ischemia in group 1. Plasma CNP levels were determined in the fifth hour of peripheral ischemia for group 2, whereas plasma CNP levels were determined in group 3 at the eighth hour of peripheral ischemia. Results: The baseline plasma CNP levels were 0.285 +/- 0.011 pmol/L in the control group. In rats with peripheral ischemia, a significant time-dependent increase was detected in plasma levels of CNP (p<0.05). The plasma CNP levels were detected as 0.350 +/- 0.015, 0.486 +/- 0.084, and 0.534 +/- 0.048 pmol/L in group 1, 2, and 3 respectively. Conclusion: Plasma CNP, an endothelium-derived vasodilator, is associated with the cellular response in ischemic tissues in a time-dependent manner.
引用
收藏
页码:615 / 619
页数:5
相关论文
共 50 条
  • [1] C-type natriuretic peptide
    Barr, CS
    Rhodes, P
    Struthers, AD
    PEPTIDES, 1996, 17 (07) : 1243 - 1251
  • [2] Detection of C-type natriuretic peptide in fetal circulation
    Stepan, H
    Walther, D
    Faber, R
    Walther, T
    JOURNAL OF PERINATAL MEDICINE, 2000, 28 (02) : 118 - 121
  • [3] Detection of C-type natriuretic peptide in normal pregnancy
    Stepan, H
    Walther, T
    Walther, D
    Faber, R
    JOURNAL OF PERINATAL MEDICINE, 1998, 26 (01) : 56 - 58
  • [4] C-Type Natriuretic Peptide and Cardiac Fibrosis
    Richards, A. Mark
    HYPERTENSION, 2011, 57 (02) : 154 - 155
  • [5] C-type natriuretic peptide in prostate cancer
    Nielsen, Soeren Junge
    Iversen, Peter
    Rehfeld, Jens F.
    Jensen, Helle Lone
    Goetze, Jens Peter
    APMIS, 2009, 117 (01) : 60 - 67
  • [6] Urinary C-Type Natriuretic Peptide
    Zakeri, Rosita
    Sangaralingham, S. Jeson
    Sandberg, Sharon M.
    Heublein, Denise M.
    Scott, Christopher G.
    Burnett, John C., Jr.
    JACC-HEART FAILURE, 2013, 1 (02) : 170 - 177
  • [7] C-type natriuretic peptide inhibits porcine oocyte meiotic resumption
    Hiradate, Yuki
    Hoshino, Yumi
    Tanemura, Kentaro
    Sato, Eimei
    ZYGOTE, 2014, 22 (03) : 372 - 377
  • [8] C-type natriuretic peptide and heart failure
    Del Ry, Silvia
    Passino, Claudio
    Emdin, Michele
    Giannessi, Daniela
    PHARMACOLOGICAL RESEARCH, 2006, 54 (05) : 326 - 333
  • [9] C-type natriuretic peptide in childhood obesity
    Cabiati, Manuela
    Sgalippa, Agnese
    Federico, Giovanni
    Del Ry, Silvia
    PEPTIDES, 2021, 145
  • [10] Regulation of C-type natriuretic peptide expression
    Sellitti, Donald F.
    Koles, Nancy
    Mendonca, Maria C.
    PEPTIDES, 2011, 32 (09) : 1964 - 1971